期刊文献+

动物细胞工程在动物生物技术中的应用 被引量:2

下载PDF
导出
摘要 动物细胞工程主要技术涉及细胞融合、细胞拆合、染色体导入和基因转移这四个方面,是从细胞水平、核质水平、染色体水平以及基因水平这四个不同层次来改造细胞。细胞工程作为科学研究的一种手段,已经渗入到生物工程的各个方面,成为必不可少的配套技术。本文从动物细胞工程在单克隆抗体和细胞因子、特殊动物、器官和组织的生产及细胞治疗、基础应用等几方面的应用进行综述。
出处 《新疆农垦科技》 2011年第6期25-29,共5页 Xinjiang Farm Research of Science and Technology
基金 新疆农垦科学院青年基金项目(供体细胞对转基因体细胞克隆羊重构胚发育的影响) 项目编号:YQJ2009-03
  • 相关文献

参考文献3

二级参考文献16

  • 1ZHOU Guang-qian,XIE Hui-qi,ZHANG Su-zhen,YANG Zhi-ming.Current understanding of dystrophin-related muscular dystrophy and therapeutic challenges ahead[J].Chinese Medical Journal,2006(16):1381-1391. 被引量:9
  • 2Paik S, Bryant J, Park C, et al. ErbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer. J Natl Cancer Inst, 1998, 90: 1361-1370.
  • 3陈强,叶韵斌,吴凡.HER-2单抗曲妥珠单克隆抗体耐药机制研究进展.[2009-11-20].http://reg.csco.org.on/reg2007/main/200706.pdf.
  • 4Antonio C, Wolff M, Elizabeth H, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol, 2007, 25:118 145.
  • 5Rakkhit R, Broglio K, Peintinger F, et al. Significant increased recurrence rates among breast cancer patients with HER-2- positive, T1a,b N0M0 tumors. San Antonio Breast Cancer Symposium Proceedings, San Antonio, Texas, USA, 2008. [2009-11-20]. http://www. abstracts2view, com/sabes/ search, php?.
  • 6Tovey SM, Marla S, Brown S, et al. Poor survival outcomes in HER-2 positive breast cancer patients with low grade, node negative turnouts: implications for trastuzumab therapy? San Antonio Breast Caneer Symposium Proceedings, San Antonio, Texas ,USA, 9008. [2009-11-20]. http://www, abstracts2view. corn/sahcs/search, php?.
  • 7Robert W, Benjamin O, Stephen B, et al. NCCN Clinical Practice Guidelines in Oncology^TM Breast Cancer V. 1. 2009. [2009-11-20]. http://www. necn. org.
  • 8Gianni L, Eiermann W, Semiglazov V, et al. Neoadjuvant trastuzumab in patients with HER-2 positive locally advanced breast cancer: primary efficacy analysis of the NOAH triai. San Antonio Breast Cancer Symposium Proceedings, San Antonio, Texas, USA, 2008. [2009-11-20]. http://www. abstracts2view.com/sabcs/search, php?.
  • 9Rugo H, Kaufman P, Tan Chiu E, et al. Survival of patients with HER-2(+) metastatic breast cancer and use of trastuzumab following progression: analysis of registHER. San Antonio Breast Cancer Symposium Proceedings, San Antonio, Texas, USA, 2008. [2009-11-20]. http://www, abstracts2view, com/sabcs/ search, php?.
  • 10Portera CC, Walshe JM, Rosing DR, et al. Cardiac toxicity and efficacy of trastuzumab combined with pertuzumab in patients with [corrected] human epidermal growth factor receptor 2-positive metastatic breast cancer. Clin Cancer Res, 2008, 14: 2710-2716.

共引文献22

同被引文献14

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部